Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 13, 2015 - Issue 12
Submit an article Journal homepage
326
Views
13
CrossRef citations to date
0
Altmetric
Drug profiles

Vorapaxar in the secondary prevention of atherothrombosis

Udaya S. Tantry“Inova Center for Thrombosis Research and Drug Development” Inova Heart and Vascular Institute, Fairfax, VA, USACorrespondence[email protected]
,
Fang Liu“Inova Center for Thrombosis Research and Drug Development” Inova Heart and Vascular Institute, Fairfax, VA, USA;Department of Neurology, Beijing Hospital, Beijing100730, China
,
Gailing Chen“Inova Center for Thrombosis Research and Drug Development” Inova Heart and Vascular Institute, Fairfax, VA, USA;Department of Cardiology, China-Japan Friendship Hospital, Beijing100029, China
&
Paul A. Gurbel“Inova Center for Thrombosis Research and Drug Development” Inova Heart and Vascular Institute, Fairfax, VA, USA
Pages 1293-1305 | Published online: 12 Nov 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jose-Angel Perez-Rivera, Jairo Monedero-Campo, Clara Cieza-Borrella & Pablo Ruiz-Perez. (2017) Pharmacokinetic drug evaluation of vorapaxar for secondary prevention after acute coronary syndrome. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 339-350.
Read now

Articles from other publishers (12)

Livia Stanger, Adriana Yamaguchi & Michael Holinstat. (2023) Antiplatelet strategies: past, present, and future. Journal of Thrombosis and Haemostasis 21:12, pages 3317-3328.
Crossref
David M. Smadja, Elisa Rossi, Skerdi Haviari, Ivan Bieche, Audrey Cras & Pascale Gaussem. (2023) Thrombin receptor PAR1 silencing in endothelial colony–forming cells modifies stemness and vasculogenic properties. Journal of Thrombosis and Haemostasis 21:12, pages 3640-3648.
Crossref
Ha Thanh Nguyen, Thu Ha Nguyen Thi, Julien Braire, Tuyet Anh Dang Thi & Tuyen Nguyen Van. (2023) Microwave‐Assisted Multicomponent Synthesis of New 6‐Arylated 5‐Hydroxy‐benzo[ a ]phenazine Derivatives and Their Potential Anti‐inflammatory Activity . ChemistrySelect 8:1.
Crossref
Wiktoria Strasenburg, Jakub Jóźwicki, Justyna Durślewicz, Błażej Kuffel, Martyna Parol Kulczyk, Adam Kowalewski, Dariusz Grzanka, Tomasz Drewa & Jan Adamowicz. (2022) Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy. Frontiers in Oncology 12.
Crossref
Tommi Tervonen, Thibaud Prawitz, Gin Nie Chua, Johanna Hyacinthe & Cathy Anne Pinto. (2022) Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. Journal of Clinical Epidemiology 144, pages 84-92.
Crossref
Zinnet Şevval Aksoyalp, Cahit Nacitarhan & Ozan Erbasan. (2021) Which proteinase-activated receptor-1 antagonist is better?: Evaluation of vorapaxar and parmodulin-2 effects on human left internal mammary artery endothelial function. Life Sciences 286, pages 120045.
Crossref
Mohamed S. Abbas, Mahmoud S. Abbas, Ali N. Harb, Roger K. Kakos, Kristian Loveridge & Hani H. Abujudeh. (2021) Periprocedural Anticoagulation and Antiplatelet Medications Management for Interventional Radiology Procedures. Current Radiology Reports 9:5.
Crossref
Joonseong Hur, Jaebong Jang & Jaehoon Sim. (2021) A Review of the Pharmacological Activities and Recent Synthetic Advances of γ-Butyrolactones. International Journal of Molecular Sciences 22:5, pages 2769.
Crossref
Kevin Bliden, Rahul Chaudhary, Athan Kuliopulos, Henry Tran, Hamid Taheri, Behnam Tehrani, Arnold Rosenblatt, Eliano Navarese, Udaya S. Tantry & Paul A. Gurbel. (2020) Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy. Journal of Thrombosis and Haemostasis 18:1, pages 23-35.
Crossref
Tomasz Przygodzki, Hassan Kassassir, Marcin Talar, Karolina Siewiera & Cezary Watala. (2019) Effects of three‐month streptozotocin‐induced diabetes in mice on blood platelet reactivity, COX ‐1 expression and adhesion potential . International Journal of Experimental Pathology 100:1, pages 41-48.
Crossref
Janina Jamasbi, Keng Ayabe, Shinya Goto, Bernhard Nieswandt, Karlheinz Peter & Wolfgang Siess. (2017) Platelet receptors as therapeutic targets: Past, present and future. Thrombosis and Haemostasis 117:07, pages 1249-1257.
Crossref
Paul A Gurbel, Aung Myat, Jacek Kubica & Udaya S Tantry. (2016) State of the art: Oral antiplatelet therapy. JRSM Cardiovascular Disease 5, pages 204800401665251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.